Skip to search formSkip to main contentSkip to account menu

IST 622

Known as: IST-622 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
Antitumor effects of IST-622, a novel synthetic derivative of chartreusin, against murine and human tumor lines following oral administration
The antitumor effects of 6-O-(3-ethoxypropionyl)-3′,4′-O-exo-benzylidenechartreusin (IST-622), a new synthetic derivative of… 
2003
2003
Pharmacokinetic and pharmacodynamic study of IST-622, a novel synthetic derivative of chartreusin, by oral administration in a phase 2 study of patients with breast cancer
Review
1993
Review
1993
[Topoisomerase inhibitors developing in Japan].
Irinotecan hydrochloride (CPT-11), topotecan, sobuzoxane, NC-190, and IST-622 are unique topoisomerase inhibitors and are… 
Review
1993
Review
1993
[DNA topoisomerase inhibitor].
DNA topoisomerases are enzymes involved in various aspects of genetic processes by catalyzing a topological change of DNA… 
Review
1992
Review
1992
[DNA topoisomerase inhibitor].
CPT-11 and Topotecan are a new semisynthetic derivative of CPT, and have been shown to inhibit DNA topoisomerase I and to have a… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)